Skip to main content
Why Ozempic Might Not Be the Miracle You Think | Dr. Vanita Rahman
GLP-1 weight loss drugs like Ozempic and Wegovy are being hailed as game-changers, but are they really safe, effective, or sustainable?
Dr. Vanita Rahman joins Chuck Carroll to unpack the data behind these billion-dollar drugs, highlighting alarming side effects, minimal long-term benefits, and industry conflicts of interest. With 129 million Americans eligible and a price tag of $1,600 per month, the stakes are massive.
This episode explores a better way forward—using food as medicine and empowering people with knowledge, not prescriptions.
Plus, Chuck opens up about his own weight loss surgery—and the one thing he wishes he knew beforehand.
